Two-dimensional transthoracic echocardiographic demonstration of reduction in fibrin content in purulent pericarditis following intrapericardial fibrinolytic agent administration

Echocardiography. 2022 Jan;39(1):146-148. doi: 10.1111/echo.15282. Epub 2021 Dec 15.

Abstract

We describe an adult patient who presented with purulent pericarditis (PP) in whom two-dimensional transthoracic echocardiography demonstrated a marked decrease in the area of the right ventricular (RV) wall together with the overlying fibrin following intrapericardial administration of a fibrinolytic agent. Documentation of this decrease by measurements performed and illustrated on two-dimensional images has not been reported previously in an adult patient with PP, to the best of our knowledge.

Keywords: constrictive pericarditis; fibrin; fibrinolytic agent; intrapericardial; pericarditis; purulent pericarditis; two-dimensional transthoracic echocardiography.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Echocardiography
  • Fibrin / therapeutic use
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Pericarditis* / diagnostic imaging
  • Pericarditis* / drug therapy
  • Pericarditis, Constrictive* / drug therapy
  • Thrombolytic Therapy

Substances

  • Fibrinolytic Agents
  • Fibrin